Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Clinical trial NCT02692599 · COMPLETED
Trial details
- NCT number
- NCT02692599
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 1150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.